KFDA to reclassify 6,879 drugs

Published: 2011-09-06 06:58:00

Updated: 2011-09-06 06:58:00

The Korea Food and Drug Administration said Thursday it plans to complete the re-classification of 6,879 medicines from 329 companies by the end of this year, after forming a special task force consisting of experts who are neutral on the issue.

By therapeutic category, there are 736 antipyret...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK